Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,000
Closed -$1.13M 617
2024
Q1
$1.13M Sell
50,000
-100,000
-67% -$2.34M 0.03% 261
2023
Q4
$3.73M Buy
150,000
+52,500
+54% +$1.02M 0.12% 97
2023
Q3
$1.67M Buy
+97,500
New +$1.62M 0.03% 265
2022
Q4
Sell
-125,000
Closed -$1.58M 236
2022
Q3
$1.58M Buy
125,000
+25,000
+25% +$438K 0.02% 684
2022
Q2
$1.82M Buy
+100,000
New +$1.87M 0.02% 676
2022
Q1
Sell
-40,000
Closed -$1.73M 166
2021
Q4
$1.73M Buy
40,000
+10,000
+33% +$493K 0.02% 601
2021
Q3
$1.58M Buy
+30,000
New +$1.82M 0.01% 573

Other funds holding PATH

UBS O'Connor's PATH Position: Q2 2024 in Review

UBS O'Connor sold out of UiPath (PATH) in Q2 2024, closing a stake of 50,000 shares — an estimated $1.13M sold.

UBS O'Connor first reported a position in PATH in Q3 2021 and held it in 7 quarters. The position peaked at $3.73M in Q4 2023. 478 funds tracked by Wall St. Rank hold PATH as of Q2 2024.

  • UBS O'Connor reported no remaining UiPath position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 50,000 UiPath shares in Q2 2024, an estimated $1.13M.
  • UBS O'Connor first reported a position in UiPath in Q3 2021 and held it in 7 quarters.
  • UBS O'Connor's UiPath position peaked at $3.73M in Q4 2023.
  • 478 funds tracked by Wall St. Rank held UiPath as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.